Metoserpate

This classification denotes a sedative and hypnotic with the molecular formula C24H32N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X3G4L02XQU, chemically known as 3.beta., 20.alpha.-yohimban-16.beta.-carboxylic acid, 11,17.alpha., 18.alpha.-trimethoxy-, methyl ester, monohydrochloride but generally known as metoserpate, which bears US NIH Compound Identifier 14443. European Medicines Agency schedules Metoserpate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08911MIG. The term METOSERPATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). METOSERPATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metoserpate under HS 29399900 and SITC 54149. As of Q4 2014, METOSERPATE remains the US FDA Preferred Term for this commodity. Metoserpate bears US NLM identifiers UMLS ID C0066470 and NCI Concept Code C76942. SMILES: O(C1C(C2C(CN3C(C2)C2[NH]C4C(C2CC3)CCC(OC)C4)CC1OC)C(=O)OC)C.